Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
27 mai 2021 07h00 HE
|
Pulmocide
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
27 mai 2021 02h00 HE
|
Pulmocide
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...